Step by Stepa HemeOncBuddy patient portal

IBR

Illustration: IBR

Say it: I-B-R

Ibrutinib, bendamustine and rituximab

IBR adds the daily pill ibrutinib to the chemotherapy and antibody combination BR, mostly for chronic lymphocytic leukemia (CLL) that has come back.

Also called: Ibrutinib-BR, Ibrutinib plus BR, BR plus ibrutinib, Ibrutinib, bendamustine and rituximab

What it is

Bendamustine (chemotherapy) and rituximab (an antibody) quickly lower the number of leukemia cells. Ibrutinib is a targeted pill that blocks a signal (BTK) CLL cells need to survive, and it keeps working after the chemotherapy is done. The goal is to control CLL for a long time. Today, many people get targeted pills without chemotherapy instead, so IBR is used less often.

Iibrutinib
Bbendamustine
Rrituximab

Often used for

The medicines in this plan

Ibrutinib
A targeted pill (BTK inhibitor) taken by mouth once a day, every day. It is usually continued after the chemotherapy ends, as long as it keeps working.
Bendamustine
Chemotherapy given through a vein on days 1 and 2 of each 28 day cycle.
Rituximab
An antibody that targets CD20, a marker on CLL cells. Given through a vein on day 1 of each cycle.

How you get it

Bendamustine and rituximab are given in an outpatient infusion clinic on days 1 and 2 of each 28 day cycle, for up to 6 cycles. The first rituximab infusion is given slowly and can take most of a day; later ones are shorter. Ibrutinib is a pill you take at home every day, and it is usually continued after the 6 cycles. Your schedule may be different.

A typical cycle

Day 1
Blood tests, then pre-medicines, then rituximab and bendamustine through a vein.
Day 2
Bendamustine through a vein (a shorter visit).
Days 1 to 28
Ibrutinib pill once a day at home, at about the same time each day.
Days 3 to 28
Recovery. Blood counts are often lowest in the second and third weeks.
After 6 cycles
Chemotherapy and rituximab stop. Ibrutinib usually continues.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Leukemia

Sources

Quick answers

What is IBR?
IBR adds the daily pill ibrutinib to the chemotherapy and antibody combination BR, mostly for chronic lymphocytic leukemia (CLL) that has come back. Ibrutinib, bendamustine and rituximab.
What does IBR stand for?
I = ibrutinib; B = bendamustine; R = rituximab.
How is IBR given?
Bendamustine and rituximab are given in an outpatient infusion clinic on days 1 and 2 of each 28 day cycle, for up to 6 cycles. The first rituximab infusion is given slowly and can take most of a day; later ones are shorter. Ibrutinib is a pill you take at home every day, and it is usually continued after the 6 cycles. Your schedule may be different.
What are the common side effects of IBR?
Low blood counts and higher infection risk. Chills, fever or itching during the first rituximab infusion. Nausea. Tiredness. Easy bruising or bleeding from ibrutinib. Diarrhea. Muscle or joint aches. Rash.
When should I call my care team during IBR?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; A fast, pounding or uneven heartbeat, or feeling faint; Bleeding that will not stop, black stools, vomiting blood, or a sudden bad headache; Shortness of breath, cough or chest pain; A blistering or peeling rash, or sores in the mouth; Very high blood pressure readings, if you check at home; A painful rash with blisters on one side of the body (shingles).

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.